| P2093 | author name string | Paul H Gordon | |
| P2860 | cites work | Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis | Q73907503 |
| | A controlled trial of recombinant methionyl human BDNF in ALS: The BDNF Study Group (Phase III) | Q77398255 |
| | Increased plasma TGF-beta1 in patients with amyotrophic lateral sclerosis | Q78351717 |
| | Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis | Q28215893 |
| | El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 |
| | Amyotrophic lateral sclerosis | Q29619516 |
| | Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force | Q33607685 |
| | Efficacy and safety of xaliproden in amyotrophic lateral sclerosis: results of two phase III trials | Q34327603 |
| | Objective tests for upper motor neuron involvement in amyotrophic lateral sclerosis (ALS). | Q34548129 |
| | Electrophysiological estimation of the number of motor units within a human muscle | Q37075966 |
| | Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis | Q43569621 |
| | Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice | Q43977943 |
| | Minocycline delays disease onset and mortality in a transgenic model of ALS. | Q44024931 |
| | Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis | Q44149270 |
| | Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction. | Q44335817 |
| | A randomized sequential trial of creatine in amyotrophic lateral sclerosis | Q44383439 |
| | A randomized, placebo-controlled trial of topiramate in amyotrophic lateral sclerosis | Q44562245 |
| | Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden | Q44907890 |
| | Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis | Q44907911 |
| | Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials | Q48570656 |
| | Disease status and use of ventilatory support by ALS patients. BDNF Study Group | Q49035573 |
| | Blinded and seeing the light, (John Noseworthy), Lou Gehrig and other tales of enlightenment). | Q50266074 |
| | Stem cell therapy in amyotrophic lateral sclerosis: a methodological approach in humans. | Q51653840 |
| | Patient compliance and the conduct and interpretation of therapeutic trials. | Q52870843 |
| | The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). | Q53535985 |
| | Measuring pseudobulbar affect in ALS | Q58173882 |
| | The FDA's new procedures for the use of investigational drugs in treatment | Q68130794 |
| | A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group | Q71074210 |
| | The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group | Q71098129 |
| | Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II | Q71177245 |
| | A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group | Q72759362 |
| | Increased oxidative damage to DNA in ALS patients | Q73082166 |
| | Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis | Q73234498 |
| P433 | issue | 1 | |
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P304 | page(s) | 48-54 | |
| P577 | publication date | 2005-02-01 | |
| P1433 | published in | Current Neurology and Neuroscience Reports | Q18206211 |
| P1476 | title | Advances in clinical trials for amyotrophic lateral sclerosis | |
| P478 | volume | 5 | |